Top news
What India's COVID-19 crisis means for Africa | Brookings
If you got the Johnson & Johnson vaccine, do you need another dose?
By Akshay Syal & Jane Weaver
Two doses of Pfizer, AstraZeneca shots effective against Delta variant: study
By barbara lewis & Alistair Smout
All coverage
South African firm to make Pfizer vaccine, first in Africa
By Carley Petesch & Andrew Meldrum
Pfizer will turn to a plant in Africa to help supply the continent with vaccines next year. (Published 2021)
By Rebecca Robbins
The Delta Variant, Covid-19 Symptoms and Vaccine Efficacy: What to Know
By Jared S. Hopkins & Robbie Whelan
Israel says Pfizer Covid vaccine is just 39% effective as delta spreads, but still prevents severe illness
By Berkeley Lovelace & Berkeley Lovelace Jr.
Pfizer-BioNTech to start producing Covid-19 vaccines in South Africa in 2022
By David McKenzie & Jeevan Ravindran
Africa demands local production of COVID vaccines
By Duncan Miriri & George Obulutsa
J&J forecasts $2.5 bln in 2021 COVID-19 vaccine sales, sets lower production target
By Manas Mishra & Carl O'Donnell
South African firm to help make Pfizer/BioNTech COVID vaccine
By Michael Erman, Wendell Roelf & Alexander Winning
J.&J. Vaccine May Be Less Effective Against Delta, Study Suggests (Published 2021)
By Apoorva Mandavilli